Flucol

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flucol

Property Description
Active Ingredients Acetaminophen, Caffeine, Phenylephrine Hydrochloride
Form Tablet, Capsule
Pharmacological Class Analgesic, Antipyretic, and Nasal Decongestant Combination
Common Use Symptomatic relief of cold and flu discomforts
Origin Synthetic/Chemically Derived

Flucol is a multi-ingredient pharmaceutical preparation and a combination product used for symptomatic relief, classified as an Analgesic, Antipyretic, and Nasal Decongestant Combination. This medicine is a synthetically derived entity, provided for oral administration as a tablet or capsule. It is defined by its triple composition, featuring three distinct active ingredients: Acetaminophen, Caffeine, and Phenylephrine Hydrochloride.


What Is the General Therapeutic Purpose of Flucol?

The general purpose of Flucol is to provide comprehensive, symptomatic treatment for the temporary relief of discomforts associated with the common cold and flu. The formulation addresses the cluster of symptoms including minor body aches, headaches, elevated body temperature (feverishness), and respiratory congestion.

The efficacy of oral decongestants like Phenylephrine in reducing nasal obstruction is pharmacologically recognized. This means the decongestant component is intended to help ease nasal stuffiness. Furthermore, Acetaminophen is an agent for the management of pain and fever. This indicates the analgesic ingredient is used for the temporary relief of aches and feverishness.


How Does the Combination Composition Work Together?

The triple-action composition ensures that relief is delivered across systemic, cognitive, and respiratory pathways. The Acetaminophen component modulates the body's response to pain and heat, while the Phenylephrine component acts locally to relieve nasal passage congestion by reducing swelling.

The inclusion of Caffeine provides a mild central nervous system effect that can temporarily counteract the fatigue and malaise often experienced during illness. This integrated approach is a distinctive characteristic of this formulation type, as it simultaneously addresses the pain, fever, and congestion associated with the cold and flu experience.

Regulatory References

  1. multi-ingredient pharmaceutical preparation
  2. combination product
  3. Analgesic, Antipyretic, and Nasal Decongestant Combination
  4. Acetaminophen
  5. Caffeine
  6. feverishness
  7. clinically recognized and supported by pharmacological studies
  8. universally accepted agent for the management of pain and fever
  9. fatigue
  10. distinctive characteristic

What side effects are possible with Flucol?

Possible side effects and safety information

The regulatory safety profile for Flucol, a combination product containing Acetaminophen, Phenylephrine, and Caffeine, is defined by the known risks associated with its active components, classified according to governmental labeling standards.


Adverse Reactions and System-Organ Classes

The officially documented adverse effects are categorized by the body system they affect. Reactions related to the Nervous System (e.g., nervousness, headache, insomnia) and Cardiac System (e.g., elevated blood pressure, tachycardia) are frequently reported due to the decongestant and stimulant components. Gastrointestinal disturbances like nausea and vomiting are also listed. Effects on the Hepatobiliary System include the risk of severe hepatic injury or failure, which is the most serious adverse reaction associated with the Acetaminophen component.

Frequency Classification Examples of Listed Effects
Common Nervousness, Insomnia, Headache
Rare Severe Cutaneous Adverse Reactions (SCARs), Anaphylaxis, Palpitations, Thrombocytopenia
Not Known Urinary retention, Dizziness

Safety Restrictions and Special Populations

Official labeling defines several safety constraints. The most critical restriction is the absolute maximum daily dosage limit for the Acetaminophen component to mitigate the risk of hepatotoxicity. Furthermore, the medicine is contraindicated for use concurrently with, or within two weeks of stopping, a Monoamine Oxidase Inhibitor (MAOI) due to the risk of severe hypertensive interactions.

Specific regulatory cautions exist for certain patient populations. Individuals with pre-existing conditions such as hypertension, heart disease, hyperthyroidism, or hepatic impairment require particular caution. Additionally, males with prostatic enlargement have an increased risk of urinary retention due to the decongestant component.

The regulatory framework emphasizes that the risk of severe hepatic injury is directly linked to the total dosage, and CNS stimulation effects may be more noticeable at the start of treatment.

Overdose and Emergency Response

Flucol Overdose and When to Seek Help

The official regulatory documents state that immediate medical attention must be sought for any suspected Flucol overdose, even if initial symptoms are not yet apparent. This urgent action is mandated due to the time-dependent nature of toxicity risk, particularly from the acetaminophen component.

Overdose manifestations are documented to affect several physiological systems. Early presentations often include gastrointestinal disturbances like Nausea, Vomiting, Abdominal Pain, and Diaphoresis (sweating). These may progress to signs of over-stimulation, such as Hypertension, Tachycardia, Restlessness, and Tremor.

The most severe, life-threatening outcomes documented in regulatory texts include Hepatotoxicity (severe liver damage or necrosis), which carries the risk of liver transplantation or death, as well as acute events like Seizures and Hypertensive Crisis.

Management involves specialized clinical procedures. The specific antidote N-acetylcysteine (NAC) is designated for the acetaminophen component. Treatment is otherwise Symptomatic and Supportive, requiring continuous Cardiac Monitoring and urgent laboratory assessments, including measurement of Serum Acetaminophen Concentration. Regulatory notes emphasize increased risk of hepatic damage in patients with Hepatic Impairment or those with complicating factors like alcohol co-ingestion.

Therapeutic Uses of Flucol

What Flucol Treats: Main Uses and Benefits

Flucol is relevant for the management of conditions involving fungi and yeasts. It supports relief from associated symptoms and may assist in reducing the risk of developing severe fungal illness in high-risk groups. It is used in managing yeast infections across various sites, including the mouth, throat, and blood, and for supportive use in patients with weakened immunity.


The medicine is applied in clinical settings to address symptom clusters in conditions like oral thrush, vaginal yeast infections, and systemic fungal diseases like cryptococcal meningitis or candidemia. It is also commonly used for fungal skin and nail manifestations (ringworm). Its use is relevant for managing symptoms that interfere with daily comfort. In contexts involving acute or unstable symptom patterns, Flucol provides supportive relief for managing serious systemic discomfort by addressing the fungal presence, which helps to moderate distressing systemic symptoms like persistent fever and fatigue.


Quick Facts

  • Supports Easing Localized Itching and Burning
  • Applied in addressing Systemic Discomfort and Fever
  • Contributes to improved comfort during skin and nail fungal issues
  • May assist in reducing the risk of fungal disease in immunocompromised patients

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The official eligibility profile for Flucol is strictly defined by regulatory agencies, primarily limiting use based on age, chronic health conditions, and specific concurrent medications. The medicine is formally allowed for use in adults and children 12 years of age and older who do not meet any exclusion criteria.

Absolute Contraindications (Prohibited Use)

Flucol must not be used by individuals with known hypersensitivity to any of its ingredients. Use is prohibited for patients taking a Monoamine Oxidase (MAO) inhibitor within the last 14 days. It is also contraindicated in patients with severe hepatic (liver) impairment, uncontrolled severe hypertension (high blood pressure), and conditions such as closed-angle glaucoma.

Age and Physiological Restrictions

Use is contraindicated in children under 12 years of age. Furthermore, regulatory guidance specifies the medicine is not recommended during both pregnancy and lactation (breastfeeding). Individuals consuming three or more alcoholic drinks daily are advised against use due to the enhanced risk of Acetaminophen-related hepatotoxicity.

Conditional Use (Caution)

Caution is required for patients with pre-existing conditions including non-severe renal or hepatic impairment, diabetes mellitus, hyperthyroidism, and prostate hypertrophy. Use in these groups should be approached with special consideration.

What should I know about interactions with other medicines?

Flucol Interactions with other medicines and products

Official regulatory information details how Flucol's interaction profile is defined by its effects on drug metabolism and cardiac function.

Flucol is classified as a moderate inhibitor of the CYP2C9 and CYP3A4 enzymes and a strong inhibitor of CYP2C19. This enzyme inhibition leads to a reduced metabolic breakdown of numerous co-administered drugs, increasing their plasma concentrations and systemic exposure. The inhibitory effect persists for approximately four to five days after discontinuation due to Flucol’s long half-life.

Pharmacokinetic and Pharmacodynamic Interaction Categories

Category Regulatory Statement Basis
Contraindicated Combinations Co-administration is forbidden with medicinal products known to prolong the QT interval and/or are metabolized by CYP3A4 (e.g., Quinidine, Cisapride, Pimozide, Terfenadine).
Major Exposure-Modifying Agents The combination with Abrocitinib should be avoided due to significantly increased systemic exposure. Co-administration with Hydrochlorothiazide increases Flucol's AUC and Cmax due to reduced renal clearance.
Increased Systemic Exposure Risk Requires caution and monitoring with substrates of inhibited enzymes, including Oral Anticoagulants (e.g., Warfarin), Phenytoin, Theophylline, Sulfonylureas, certain Statins, and Immunosuppressants (e.g., Tacrolimus, Cyclosporine).
Population-Specific Notes The risk of QT prolongation when combined with Amiodarone requires caution, notably with high doses of Flucol.

This structure reflects the mandated constraints and monitoring requirements officially documented in government-issued regulatory labeling.

Mechanism of Action

The physiological actions of this combination product are achieved through three distinct, yet complementary, mechanistic domains that modulate central and peripheral systems.

Central Suppression of Prostaglandin Signaling

This domain focuses on the action of Acetaminophen, which functions as an inhibitor of Cyclooxygenase (COX) enzymes primarily within the Central Nervous System. This interference suppresses the local synthesis of Prostaglandin E2 ( PGE2), a mediator responsible for modulating the hypothalamic set-point and nociceptive pathways. The result is a dual physiological effect: the lowering of the hypothalamic set-point, promoting systemic heat loss (antipyresis), and the modulation of central pain pathways (analgesia).

Localized Vasoconstriction via Alpha-1 Receptor Activation

This domain is driven by Phenylephrine, which acts as a direct-acting agonist for Alpha-1 (alpha1) Adrenergic Receptors located on the smooth muscle of blood vessels in the nasal lining. Activation of these receptors triggers a cascade leading to vasoconstriction, physically narrowing the arterioles. This mechanism reduces blood flow and volume in the nasal tissues, which shrinks the swollen mucosal lining and contributes to reducing the degree of tissue engorgement and airway resistance.

Adenosine Receptor Antagonism and Adjuvancy

The final domain involves Caffeine, which functions as a non-selective competitive antagonist of Adenosine Receptors in the brain. By blocking adenosine's inhibitory signals, Caffeine increases neuronal activity, which produces a psychostimulant effect that modulates central inhibitory signaling resulting in increased alertness. Furthermore, this central antagonism provides pharmacodynamic adjuvancy to the analgesic component, contributing to the modulation of central nociceptive pathways.

Dosage and Administration Information

How to Use Flucol (Fluconazole)

The following details the administration and dosing of Flucol.


Administration Scope

Feature Instruction
Approved Routes Oral (capsules, tablets, suspension) and Intravenous (IV) Infusion
Timing Relative to Meals Oral forms may be taken with or without food.
IV Infusion Rate Administer at a maximum rate not exceeding 200 mg per hour.
Route Switch The daily dose remains the same when switching between oral and IV administration.

Dosing and Schedule

Flucol is typically administered once daily. For certain conditions, a single oral dose or a once-weekly schedule may be used. A loading dose—twice the usual daily dose—may be administered on Day 1 to achieve plasma concentration quickly.

Population-Specific Adjustments

  • Renal Impairment: The dosage must be reduced for patients with impaired renal function (creatinine clearance less than or equal to 50 mL/min). Patients undergoing hemodialysis should receive 100% of the recommended dose after each dialysis session.
  • Pediatrics and Neonates: Dosing is weight-based (mg/kg). Neonates (in the first weeks of life) require extended dosing intervals (e.g., every 72 hours), which differs from standard daily adult dosing.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Flucol


Evidence for Symptomatic Relief of Cold and Flu

This section summarizes the structure of clinical research, primarily Randomized Controlled Trials (RCTs), used to evaluate Flucol for addressing key cold and flu symptoms: fever, pain, and nasal stuffiness. In these studies, participants experiencing acute, mild-to-moderate symptoms received the combination product, a placebo, or a single active ingredient. Researchers monitored how symptoms evolved using standardized scoring scales for outcomes related to physical discomfort (like headache and aches) and objective measures for nasal congestion.

Comparing the Combination to Individual Components

The evidence base includes studies that explored whether the complete triple-component product was observed to elicit a different symptomatic response compared to taking only one active ingredient (e.g., the analgesic alone). These comparative trials examined short-term symptom changes to understand how the combined components were observed in studies focusing on episodes where symptoms become more noticeable.


Study Duration and Follow-up Assessments

The research structure is characterized by relatively short-term follow-up durations. Key research data are derived from studies observing responses over defined time intervals, often four to six hours following a single dose. While trials assessed the response over the full course of illness (typically three to seven days), the research structure provides limited information on the overall course or duration of the underlying illness. Follow-up durations were limited, meaning there is limited information for long-term outcomes.


Research in Specific Patient Groups

The majority of the evidence supporting the use of this combination product was derived from studies conducted in healthy adults (ages 18 to 65). Data for certain groups remain insufficient. For instance, while some studies included adolescents (12 years and older), the sample sizes were modest. Furthermore, there are few data available for older adults, meaning the findings reflect the group patterns observed in the general populations studied in the RCTs.


What Remains Uncertain in the Research Landscape

Long-term effects are not fully established, as the current research structure focuses almost entirely on the acute phase of illness. Additionally, the specific role of the Caffeine component is not consistently isolated across all studies of the combination. Evidence quality varies across studies, and some regulatory reviews have noted that subgroup findings are uncertain due to modest sample sizes and trial design heterogeneity.

Key Studies & References

  1. Acetaminophen Drug Information (MedlinePlus/NIH)

Frequently Asked Questions (FAQ)

Common questions about Flucol (FAQ)


Q: How quickly does Flucol start working after taking it?

A: Regulatory documents indicate that the analgesic component, Acetaminophen, typically begins relieving discomfort quickly, often within 15 to 30 minutes after a dose. The effects of the decongestant and other components are also generally noticed soon after administration. This type of onset is typical for medicines intended for temporary symptomatic relief.


Q: What is the expected duration of Flucol's effects?

A: Flucol is designed for temporary symptomatic relief. According to official dosing schedules, the effect of a single dose is generally expected to last between four and six hours. This duration determines the interval at which the medicine may be taken again, as symptoms persist.


Q: Is Flucol safe for long-term use?

A: Regulatory labeling specifies that this product is intended for short-term symptomatic relief only. When used for self-medication, official warnings state that use should be discontinued if symptoms persist or worsen after seven days, or if fever lasts more than three days. It is not described in official information as being intended for long-term management.


Q: Can Flucol be split or crushed?

A: The official administration guidelines define the use of the product as the intact oral dosage form (capsule or tablet). Unless the product is specifically scored by the manufacturer, regulatory documents generally do not provide instructions for splitting or crushing the dosage form. The product is generally prepared to be swallowed as the intact dosage form.


Q: What should I know about Flucol and driving?

A: Due to the presence of components that can potentially cause side effects such as nervousness, dizziness, or insomnia, regulatory cautions exist regarding operating machinery or driving. Official product information includes a caution regarding operating machinery or driving until you are aware of how the medicine affects your alertness.


Q: Is it mandatory to finish the entire course of Flucol?

A: Flucol is classified as a medicine for the temporary, symptomatic relief of cold and flu discomforts. It is typically taken only for as long as symptoms persist, and use is generally not defined as a fixed course that must be completed.


Q: What are the limitations of the existing research on Flucol?

A: Official research reviews primarily focus on the acute, short-term relief of symptoms associated with cold and flu. Reviews note there is limited information on long-term outcomes and that data for specific patient subgroups, such as older adults and adolescents, are modest in volume.


Q: Does Flucol contain a steroid?

A: No, this medicine does not contain any steroid component. Official regulatory documents list the active ingredients as Acetaminophen, Caffeine, and Phenylephrine Hydrochloride. It is classified as an Analgesic, Antipyretic, and Nasal Decongestant Combination.


Q: Does Flucol have a sedative effect?

A: No, Flucol is not described in official labeling as having a sedative effect. It contains Caffeine, which is classified as a central nervous system stimulant. Known side effects related to the nervous system include insomnia (difficulty sleeping) and nervousness, which are stimulating effects.


Q: Is Flucol a controlled substance?

A: No, Flucol, which contains the combination of Acetaminophen, Caffeine, and Phenylephrine, is not classified as a federally controlled substance by government regulatory bodies. Its components are commonly found in non-prescription cold remedies.


Q: What happens if a dose of Flucol is missed?

A: According to standard regulatory guidance, if a dose is missed and the medicine is taken regularly, the missed dose should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular schedule continued. Official guidelines indicate that a double dose should not be taken to make up for a missed dose.


Q: Can Flucol be used by children?

A: Official regulatory labeling defines the medicine as allowed for use only in adults and children who are 12 years of age and older. Use is formally prohibited for children under 12 years of age due to safety constraints.


Q: Is there a maximum age limit for using Flucol?

A: Regulatory documents define a minimum age of 12 for use but do not specify an absolute maximum age limit. However, certain conditions more common in older adults, such as severe hypertension or heart disease, are listed in the official warnings and contraindications for use.


Q: Does Flucol interact with birth control pills?

A: Official regulatory documents describing the interaction profile of Flucol do not list specific warnings or cautions regarding co-administration with oral hormonal contraceptives. The main interactions concern other medicines that affect liver enzymes or heart rhythm.


Q: Is Flucol only available by prescription?

A: This type of combination medicine is primarily regulated for non-prescription (Over-the-Counter, or OTC) use for the temporary relief of cold and flu symptoms. It is not typically restricted to prescription-only status.


Q: Does Flucol appear in drug tests?

A: Flucol contains components that are not classified as controlled substances. While some decongestant ingredients may lead to an initial non-negative screening result, they typically do not result in a confirmed positive drug test during the mandatory second-step confirmation process.


Q: Is there a risk of withdrawal symptoms when stopping Flucol?

A: Regulatory information does not typically discuss severe withdrawal symptoms for this combination product. However, abrupt cessation of products containing the stimulant component, Caffeine, can be associated with symptoms such as temporary headache and tiredness.


Q: What are the known interactions between Flucol and herbal supplements?

A: Regulatory warnings advise caution with certain herbal supplements. Regulatory warnings note that combinations with sympathomimetic agents like Ephedra alkaloids (Ma Huang) may pose a risk of severe cardiovascular effects.


Q: Why is Flucol sometimes used with other medicines?

A: Flucol is itself a combination product designed to address multiple symptoms of cold and flu simultaneously. It contains three distinct active ingredients (analgesic, antipyretic, and decongestant) whose combined use targets the cluster of pain, fever, and nasal congestion.


Q: Are there any specific laboratory tests needed while taking Flucol?

A: Regulatory information recommends that healthcare providers and lab workers are aware of Flucol use, as the medicine may affect the results of certain laboratory tests. Clinical monitoring of hepatic (liver) function is also noted as being recommended, especially in patients with pre-existing conditions or risk factors.


Q: Does Flucol interact with common vaccines?

A: Specific regulatory guidance addresses the use of the analgesic component (Acetaminophen) in relation to common vaccines. Regulatory guidance indicates that administration of the analgesic component around the time of vaccination may potentially alter the vaccine’s immunological effects.


Q: Can Flucol cause difficulty sleeping?

A: Yes, official regulatory labeling lists insomnia (difficulty sleeping) as a common side effect of Flucol. This effect is attributed to the presence of the stimulant and decongestant components in the formulation.


Q: What kind of studies support the use of Flucol?

A: The evidence supporting the use of Flucol is primarily derived from Randomized Controlled Trials (RCTs) and comparative trials. These studies evaluate its effectiveness in providing symptomatic relief for cold and flu discomforts and establish the known benefits.


Q: Do studies show a difference in effect based on age or gender?

A: Official research reviews note that the majority of the evidence is based on studies of healthy adults. Data for specific subgroups, such as older adults and adolescents, are considered modest. The specific findings based on gender are generally not conclusively established in the available research data.


Q: How is the safety of Flucol monitored after it is released to the public?

A: The safety of Flucol is continuously monitored through the regulatory process known as pharmacovigilance (or post-marketing surveillance). This includes ongoing scientific review of reported adverse events, which may result in updates to product labeling or warnings as needed.


Q: Why is Flucol only available by prescription?

A: This question reflects a common misunderstanding, as this type of product is typically regulated for non-prescription (Over-the-Counter, or OTC) use for the temporary relief of cold and flu symptoms. It is not usually restricted to prescription-only status.

How should Flucol be stored and disposed of?

How to Store and Dispose of Flucol

Flucol (Acetaminophen, Caffeine, and Phenylephrine HCl) must be stored according to official regulatory requirements to maintain its stability.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C) (Excursions 15 C to 30 C)
Container Keep in the original container and tightly closed
Protection Store in a dry place, protected from excessive moisture and heat
Child Safety Keep out of the sight and reach of children

Disposal Instructions

To dispose of unused or expired Flucol, utilize a community drug take-back program if available. If a program is not available, mix the medicine with an unappealing substance, place the mixture in a sealed container, and dispose of it in the household trash. Do not flush the medicine down the toilet or pour it down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flucol found in:

A-Z Index: